Synfacts, Table of Contents Synfacts 2024; 20(06): 0654DOI: 10.1055/s-0043-1774829 Innovative Drug Discovery and Development Intermolecular Chalcogen Bonding between Galectin-3 and an Orally Bioavailable Antagonist Contributor(s): Antonia F. Stepan (Roche) , Nicholas A. Meanwell (Baruch S. Blumberg Institute, U. Michigan, Rutgers U.) Recommend Article Abstract Buy Article Key words Key wordschalcogen bonding - drug–target interactions - carbohydrates - galectin 3 antagonist Full Text